Orthofix MedicalOFIX
About: Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Employees: 1,634
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
317% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 6
15% more funds holding
Funds holding: 130 [Q2] → 149 (+19) [Q3]
9% more capital invested
Capital invested by funds: $498M [Q2] → $542M (+$43.2M) [Q3]
2% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 47
9.34% less ownership
Funds ownership: 100.16% [Q2] → 90.82% (-9.34%) [Q3]
20% less funds holding in top 10
Funds holding in top 10: 5 [Q2] → 4 (-1) [Q3]
97% less call options, than puts
Call options by funds: $5K | Put options by funds: $199K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Roth MKM Jason Wittes 63% 1-year accuracy 10 / 16 met price target | 19%upside $22 | Buy Reiterated | 8 Nov 2024 |
Stifel Mathew Blackman 64% 1-year accuracy 9 / 14 met price target | 29%upside $24 | Buy Upgraded | 8 Nov 2024 |
Financial journalist opinion
Based on 11 articles about OFIX published over the past 30 days